QPS, a CRO, has expanded its global footprint with new clinics in the Netherlands and India. QPS Netherlands recently opened a second clinic, positioned on the grounds of the Medical Center Leeuwarden (MCL), in the Netherlands. While initial studies will focus on neurodegenerative diseases like Alzheimer’s disease and Parkinson’s disease, the clinic will ultimately be open to studies in a wide variety of disease states. According to Izaak den Daas, Ph.D., Director of Patient Studies at QPS Ne...